APOLLO CANCER CENTRES (ACC)- FIRST PRIVATE HOSPITAL IN INDIA TO SUCCESSFULLY COMPLETE CarTCELL THERAPY - NOW INTRODUCES " MADE IN INDIA",CAR T CELL PROGRAM.

Apollo Cancer Centre (ACC),successfully complete CAR-T cell program and to further augment it,the hospital group will now provide access "Made In India" CAR-T cell therapy.CAR-T cell therapies,often known as ""Living Drugs' involve the extraction of a patient's T-Cells (a type of white blood cells whose function is to fight cancer cells,through a process known as Aphersis.These T-Cells are then genetically modified by a safe vehicle (Viral Vector) in a controlled laboratory setting,so that they express modified connectors on their surface called Chimeric Antigen Receptors (CAR's).These CAR's are specifically designed to recognise a protein which is abnormally expressed on certain cancer cells.They are then multiplied to a desired dose,and infused directly into the patient.

CAR-T cell therapies have gained global recogntion for their unparalleled success in transforming the lives of patients with challenging B-cell malignancies. Over 25,000 patients have benefitted worldwide from this therapeutic model.

Dr.Aditya Murali,Senior consultant - Medical & Haemato Oncology,ACC,Bangalore ,sharing insights into the success of the program,he said"having successfully treated patients with imported drugs,we are now poised to treat them with indigenously built therapy".

Dr.Neema Bhat,Consultant- Haematology & Paediatric Oncology,ACC,Bangalore said,"This milestone signifies a new chapter in our fight against cancer,offering renewed hope &possibilities to those battling these conditions".

On this occassion,Mr.Dinesh Madhavan,President,Group Oncology & International,Apollo Hospitals Enterprises Limited,said,"The indigenously built CAR-T treatment,NexCAR19 reflects our commitment to provide transformative & cutting edge cancer care.Apollo Cancer Centres is not just changing the narrative,we are rewriting the possibilities of giving better treatment outcome for cancer patients across India & beyond'.

Dr.Manish Mattoo,CEO,Karnataka region,Apollo Hospitals, said," we are proud to be the first in India to achieve the milestone of groundbreaking success in CAR-T cell Therapy & this achievement reflects our dedication to pushing healthcare boundaries & delivering impactful solutions to the community".

In a layman's language,CAR-T cell therapy  reprogramme the body's immunity by harnessing the resources of the  body of the patient to fight by using the body's immunity.This treatment is mainly used for blood cancer Now.